https://investorshangout.com/post/view?id=6807058
___
Jumping to Google:
CCR5's Role in Brucella Infection:
Immune Response: Brucella infection triggers the host's immune system, and CCR5 helps coordinate the arrival of immune cells to fight the bacteria.
Gene Expression: Studies analyzing gene expression in acute human brucellosis show that genes like CCR5 can be downregulated (reduced) in certain immune cells (like PBMCs and PMNs), suggesting complex regulation during the infection.
___
CCR5, a chemokine receptor, plays a crucial role in both bone remodeling (via osteoclast function) and the immune response, particularly against bacteria like Staphylococcus aureus that cause osteomyelitis; its absence or the CCR5-delta32 mutation (CCR5Δ32) can be protective, as it impairs immune cell entry and Staph virulence, but it also affects normal bone cell function, suggesting a complex dual role where its deficiency might hinder bone repair while potentially stopping infection.
___
(Chemokine Receptor Type 5) and Chlamydia trachomatis (Ct) are linked because CCR5 helps immune T-cells get to the genital tract to fight the infection, but this same inflammation (driven partly by CCR5) can also lead to complications like (Pelvic Inflammatory Disease) or (CiReA). While CCR5 helps clear the bacteria by allowing immune cells in, its role in intense inflammation also means some people with a genetic CCR5 deletion () might have less severe long-term damage (like fallopian tube damage) despite the infection, highlighting a complex balance between protection and pathology, say National Institutes of Health (NIH) research and this ScienceDirect article.
___
How CCR5 Works in Toxoplasma Infection:
Immune Cell Trafficking: CCR5 helps direct immune cells, especially Natural Killer (NK) cells and CD8+ T cells, to sites of Toxoplasma infection in tissues, particularly the intestines, helping to fight the parasite.
___
CCR5 (C-C chemokine receptor type 5) plays a dual role in leishmaniasis, acting as a crucial entry point for the parasite into macrophages early in infection and influencing immune cell traffic, with high expression often linked to severe or delayed healing skin lesions by attracting pathogenic CD8+ T cells, while CCR5-blocking drugs like maraviroc show promise in reducing inflammation, highlighting CCR5 as a therapeutic target for host-directed treatment.
___
CCR5's role in Chagas and schistosomiasis is complex, acting as a double-edged sword: it helps control initial infection (like T. cruzi in Chagas, S. mansoni in schisto) by recruiting immune cells, but its overexpression also fuels damaging inflammation and fibrosis, especially in chronic Chagas heart disease and severe schistosomiasis liver fibrosis, highlighting CCR5's dual role in immunity and pathology, influenced by host genetics.
___
Just a brainstorm on some potential Rare Diseases.
Calling Max Lataillade.
Max....Max....
Lol.